Exploiting evolutionary steering to induce collateral drug sensitivity in cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Exploiting evolutionary steering to induce collateral drug sensitivity in cancer
Authors
Keywords
-
Journal
Nature Communications
Volume 11, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-04-21
DOI
10.1038/s41467-020-15596-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evaluating stably expressed genes in single cells
- (2019) Yingxin Lin et al. GigaScience
- Spatial Heterogeneity and Evolutionary Dynamics Modulate Time to Recurrence in Continuous and Adaptive Cancer Therapies
- (2018) Jill A. Gallaher et al. CANCER RESEARCH
- An Acquired Vulnerability of Drug-Resistant Melanoma with Therapeutic Potential
- (2018) Liqin Wang et al. CELL
- Integrating single-cell transcriptomic data across different conditions, technologies, and species
- (2018) Andrew Butler et al. NATURE BIOTECHNOLOGY
- Antimalarial proteasome inhibitor reveals collateral sensitivity from intersubunit interactions and fitness cost of resistance
- (2018) Laura A. Kirkman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Patient-derived organoids model treatment response of metastatic gastrointestinal cancers
- (2018) Georgios Vlachogiannis et al. SCIENCE
- Establishment and characterization of two cabazitaxel-resistant prostate cancer cell lines
- (2018) Kazuaki Machioka et al. Oncotarget
- Rare Cell Detection by Single-Cell RNA Sequencing as Guided by Single-Molecule RNA FISH
- (2018) Eduardo Torre et al. Cell Systems
- HIV
- (2018) Jade Ghosn et al. LANCET
- Optimizing Cancer Treatment Using Game Theory
- (2018) Katerina Stanková et al. JAMA Oncology
- Aurora kinase A drives the evolution of resistance to third-generation EGFR inhibitors in lung cancer
- (2018) Khyati N. Shah et al. NATURE MEDICINE
- New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
- (2018) Anushka Dongre et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance
- (2017) Sydney M. Shaffer et al. NATURE
- An approach to suppress the evolution of resistance in BRAFV600E-mutant cancer
- (2017) Yaohua Xue et al. NATURE MEDICINE
- EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
- (2017) Tsukasa Shibue et al. Nature Reviews Clinical Oncology
- Integrating evolutionary dynamics into treatment of metastatic castrate-resistant prostate cancer
- (2017) Jingsong Zhang et al. Nature Communications
- The dawn of the liquid biopsy in the fight against cancer
- (2017) Irma G. Domínguez-Vigil et al. Oncotarget
- In This Issue
- (2016) CELL
- Stochasticity in the Genotype-Phenotype Map: Implications for the Robustness and Persistence of Bet-Hedging
- (2016) Daniel Nichol et al. GENETICS
- Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition
- (2016) Aaron N Hata et al. NATURE MEDICINE
- Exploiting evolutionary principles to prolong tumor control in preclinical models of breast cancer
- (2016) Pedro M. Enriquez-Navas et al. Science Translational Medicine
- Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancer
- (2016) Beth O. Van Emburgh et al. Nature Communications
- Stochasticity in the Genotype-Phenotype Map: Implications for the Robustness and Persistence of Bet-Hedging
- (2016) Daniel Nichol et al. GENETICS
- The pan-HDAC inhibitor panobinostat acts as a sensitizer for erlotinib activity in EGFR-mutated and -wildtype non-small cell lung cancer cells
- (2015) Gabriele Greve et al. BMC CANCER
- Biological and Therapeutic Impact of Intratumor Heterogeneity in Cancer Evolution
- (2015) Nicholas McGranahan et al. CANCER CELL
- Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients
- (2015) Giulia Siravegna et al. NATURE MEDICINE
- Studying clonal dynamics in response to cancer therapy using high-complexity barcoding
- (2015) Hyo-eun C Bhang et al. NATURE MEDICINE
- Evolutionary consequences of drug resistance: shared principles across diverse targets and organisms
- (2015) Diarmaid Hughes et al. NATURE REVIEWS GENETICS
- Collateral sensitivity of antibiotic-resistant microbes
- (2015) Csaba Pál et al. TRENDS IN MICROBIOLOGY
- Using a Sequential Regimen to Eliminate Bacteria at Sublethal Antibiotic Dosages
- (2015) Ayari Fuentes-Hernandez et al. PLOS BIOLOGY
- Steering Evolution with Sequential Therapy to Prevent the Emergence of Bacterial Antibiotic Resistance
- (2015) Daniel Nichol et al. PLoS Computational Biology
- Sequenza: allele-specific copy number and mutation profiles from tumor sequencing data
- (2014) F. Favero et al. ANNALS OF ONCOLOGY
- Tumour heterogeneity and the evolution of polyclonal drug resistance
- (2014) Rebecca A. Burrell et al. Molecular Oncology
- Integrating mapping-, assembly- and haplotype-based approaches for calling variants in clinical sequencing applications
- (2014) Andy Rimmer et al. NATURE GENETICS
- Pesticide-Induced Release From Competition Among Competing Aedes aegypti and Aedes albopictus (Diptera: Culicidae)
- (2013) Barry W. Alto et al. JOURNAL OF MEDICAL ENTOMOLOGY
- Tumour heterogeneity and cancer cell plasticity
- (2013) Corbin E. Meacham et al. NATURE
- Use of Collateral Sensitivity Networks to Design Drug Cycling Protocols That Avoid Resistance Development
- (2013) L. Imamovic et al. Science Translational Medicine
- Collateral sensitivity as a strategy against cancer multidrug resistance
- (2012) Kristen M. Pluchino et al. DRUG RESISTANCE UPDATES
- Exploiting Evolution To Treat Drug Resistance: Combination Therapy and the Double Bind
- (2012) David Basanta et al. MOLECULAR PHARMACEUTICS
- Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer
- (2012) Sandra Misale et al. NATURE
- The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers
- (2012) Luis A. Diaz Jr et al. NATURE
- Clonal evolution in cancer
- (2012) Mel Greaves et al. NATURE
- A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
- (2010) Sreenath V. Sharma et al. CELL
- Allele-specific copy number analysis of tumors
- (2010) P. Van Loo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Lessons from Applied Ecology: Cancer Control Using an Evolutionary Double Bind
- (2009) R. A. Gatenby et al. CANCER RESEARCH
- Adaptive Therapy
- (2009) R. A. Gatenby et al. CANCER RESEARCH
- Evolutionary-thinking in agricultural weed management
- (2009) Paul Neve et al. NEW PHYTOLOGIST
- Is resistance useless? Multidrug resistance and collateral sensitivity
- (2009) Matthew D. Hall et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Failure of CDKN2A/B (INK4A/B-ARF)-mediated tumor suppression and resistance to targeted therapy in acute lymphoblastic leukemia induced by BCR-ABL
- (2008) C. G. Mullighan et al. GENES & DEVELOPMENT
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now